Back to Oncology Hub
CAR-T & Immunotherapy
China CD19 CAR-T cost advantage vs Kymriah; solid tumor trial access.
Medical highlights
CD19 CAR-T pricing; solid tumor trials
Target patients
Relapsed hematologic malignancy; advanced solid tumor trial seekers
Related guides & articles
From $80,000 USD (varies by regimen and center)
Get treatment plan and quoteMedical disclaimer
MediLink is a Medical Travel Coordinator, not a healthcare provider. Indications and regimens must be confirmed by MDT or your treating physician.